Jesse Chen

Jesse Chen is a highly experienced biomedical professional currently serving as Co-Founder and Chief Technology Officer at TRIANA Biomedicines since January 2021. In addition, Jesse co-founded Avilar Therapeutics, where roles include Advisor and VP of Research since January 2020. Prior experience includes Entrepreneur-in-Residence at RA Capital Management, LLC, and various leadership positions at Kymera Therapeutics, including Senior Director of Discovery. Jesse's career began with significant contributions at Moderna Therapeutics, Millennium: The Takeda Oncology Company, and Massachusetts General Hospital, where work focused on cancer research and chemical genetic systems. Jesse holds a PhD in Biological Chemistry from the Massachusetts Institute of Technology and a BS in Biochemistry from Nanjing University.